Transfer of KPC-2 carbapenemase from Klebsiella pneumoniae to Enterobacter cloacae in a patient receiving meropenem therapy

dc.contributorUniversidade de São Paulo (USP)
dc.contributorHosp Base Sao Jose do Rio Preto
dc.contributorAdolfo Lutz Inst
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2018-11-26T15:44:35Z
dc.date.available2018-11-26T15:44:35Z
dc.date.created2018-11-26T15:44:35Z
dc.date.issued2017-07-01
dc.identifierDiagnostic Microbiology And Infectious Disease. New York: Elsevier Science Inc, v. 88, n. 3, p. 287-289, 2017.
dc.identifier0732-8893
dc.identifierhttp://hdl.handle.net/11449/159596
dc.identifier10.1016/j.diagmicrobio.2017.04.004
dc.identifierWOS:000404692800017
dc.identifierWOS000404692800017.pdf
dc.description.abstractThe horizontal transfer of a plasmid bearing the bla(Kpc-2) gene from K. pneumoniae to E. cloacae infecting the respiratory tract of a patient during meropenem therapy was elucidated. This finding is particularly worrisome, since these drugs are of last resort for multidrug-resistant Gram-negative pathogens. (C) 2017 Elsevier Inc. All rights reserved.
dc.languageeng
dc.publisherElsevier B.V.
dc.relationDiagnostic Microbiology And Infectious Disease
dc.relation1,157
dc.rightsAcesso aberto
dc.sourceWeb of Science
dc.subjectKlebsiella pneumoniae
dc.subjectEnterobacter cloacae
dc.subjectbla(Kpc-2)
dc.subjectHorizontal gene transfer
dc.subjectPlasmid
dc.titleTransfer of KPC-2 carbapenemase from Klebsiella pneumoniae to Enterobacter cloacae in a patient receiving meropenem therapy
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución